The US Food and Drug Administration (FDA) has issued draft guidance that proposes a uniform system for classifying protocol deviations in clinical studies to assist sponsors, clinical investigators, ...

In this free webinar, gain insight into why eligibility is a high-impact point for protocol deviation prevention. The featured speakers will discuss how to drive protocol compliance with centralized ...

Industry groups are asking the US Food and Drug Administration (FDA) for more clarity about a proposed uniform system for classifying protocol deviations in clinical studies. They say clarification is ...

Please could you give a brief introduction to radiotherapy? Radiotherapy is a key component of cancer therapy. A majority of cancer patients get radiotherapy in some form at some point in their ...

CARY, N.C., Aug. 25, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG Total Training, the ...

The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer. This is an ASCO Meeting Abstract from the 2012 Quality Care Symposium. This abstract does ...

Reports of noncompliance or protocol deviations must be submitted to the IRB within 48 hours of discovery. Please see this guidance document on how to submit reports. An "incident" should be submitted ...

In the June 2008 “Protocol Review” column, there was a discussion about whether performing fewer procedures than originally planned constitutes a significant deviation that ought to be reported to ...

Evaluating compliance of NCCN cancer and chemotherapy-induced anemia guidelines in a community healthcare setting. This is an ASCO Meeting Abstract from the 2020 ASCO Quality Care Symposium. This ...

Both the Animal Welfare Act regulations and the Public Health Service Policy make it clear that prior IACUC approval is required for research procedures using animals. Carrying out procedures that ...